
- Anatomically-designed domed endplate
- Keel-less design with lateral spikes
- One-step insertion
Centinel Spine is focused exclusively on total disc replacement. Our prodisc platform is the only one in the U.S. approved for one- and two-level use in both the cervical and lumbar spine.
Fusion permanently eliminates movement at the treated level. Total disc replacement removes the damaged disc and replaces it with an implant designed to restore disc height and preserve motion. We build the prodisc platform for that one purpose, in the cervical and the lumbar spine.
Four cervical systems and one lumbar system, all from a common motion-preserving design philosophy.
FDA approval for one-level and two-level procedures across cervical and lumbar indications.
Close to 100 implant configurations across fixation methods, endplate geometries, footprints and disc heights, so surgeons can match the disc to the patient.




prodisc C Vivo, prodisc C SK and prodisc C Nova are FDA-approved for both 1- and 2-level use. prodisc C is FDA-approved for 1-level use only. The prodisc C Total Disc Replacement has been determined to be safe and effective in the treatment of intractable symptomatic cervical disc disease (SCDD) at one level from C3 to C7. Please refer to the instructions for use for full indications, contraindications, warnings and precautions.
A novel application of the established ball and socket. A fixed core and an optimized core radius together provide stability while resisting shear forces, and facilitate controlled motion to protect the facet complex.
The fixed nature of the core, as opposed to a mobile or floating core, keeps the center of rotation stable throughout the life of the implant.
Engineered to provide coupled motion: controlled translation with flexion-extension.
Cobalt-chromium endplates, ultra-high molecular weight polyethylene inlays and titanium surface coatings used for decades in spine and large-joint arthroplasty.
One instrument set supports all configurations for the majority of the cervical portfolio, and one set for the lumbar portfolio.
Revision rate for prodisc L total disc replacement over a 7 to 21 year follow-up period.
Marnay et al., JBJS, 2025Fewer adjacent-level surgical interventions at seven years with prodisc C compared to spinal fusion.
Janssen et al., JBJS, 2015Of patients with radiographic motion maintained within a normal functional range following prodisc L.
Zigler JE et al., Spine, 2007More than 590 peer-reviewed clinical papers evaluate prodisc outcomes, biomechanics and long-term performance, including over 60 studies reporting extended long-term follow-up.
Clinical publicationsStructured surgeon education programs, surgical technique resources and a team of clinical support professionals across the U.S. and 35 countries.
Medical educationre disc over is our spine health education and patient support program.
Visit re disc overFirst generation prodisc lumbar disc first implanted in Europe.
FDA approves prodisc L for one-level use.
FDA approves prodisc C.
prodisc L becomes the only TDR system approved in the U.S. for two-level lumbar use.
Single-level FDA approval for prodisc C Vivo, C SK and C Nova.
Two-level FDA approval for prodisc C Vivo and C SK.
Two-level FDA approval for prodisc C Nova.
Questions about the portfolio, surgical technique or medical education. We will connect you with the right person.